PFE vs ROIV · P/E 20, rev $15.03B vs rev $8.3M
Pfizer Inc (PFE) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the PFE and ROIV stock pages for the full models.
Not investment advice.